Kim J, Nam Y, Jeon D, Choi Y, Choi S, Hong C
Exp Mol Med. 2025; .
PMID: 40087529
DOI: 10.1038/s12276-025-01422-3.
Bisson J, Gordillo M, Kumar R, de Silva N, Yang E, Banks K
Elife. 2025; 13.
PMID: 40080060
PMC: 11906159.
DOI: 10.7554/eLife.100797.
Gao Q, Hofer F, Filbeck S, Vermeulen B, Wurtz M, Neuner A
Nat Commun. 2025; 16(1):2453.
PMID: 40074789
PMC: 11903878.
DOI: 10.1038/s41467-025-57729-2.
Gao J, Ding M, Xiyang Y, Qin S, Shukla D, Xu J
J Immunol. 2025; 214(2):238-252.
PMID: 40073244
PMC: 11878994.
DOI: 10.1093/jimmun/vkae019.
Chiang J, Shang Z, Rosales T, Cai L, Chen W, Cai F
Sci Adv. 2025; 11(11):eadt1241.
PMID: 40073141
PMC: 11900879.
DOI: 10.1126/sciadv.adt1241.
Podocyte A20/TNFAIP3 Controls Glomerulonephritis Severity via the Regulation of Inflammatory Responses and Effects on the Cytoskeleton.
Kohler P, Ribeiro A, Honarpisheh M, von Rauchhaupt E, Lorenz G, Li C
Cells. 2025; 14(5).
PMID: 40072109
PMC: 11898495.
DOI: 10.3390/cells14050381.
Multiplexed base editing identifies functional gene-variant-context interactions.
Acosta J, Johnson G, Gould S, Dong K, Lendner Y, Detres D
bioRxiv. 2025; .
PMID: 40060482
PMC: 11888363.
DOI: 10.1101/2025.02.23.639770.
Salmonella exploits LRRK2-dependent plasma membrane dynamics to invade host cells.
Zhu H, Sydor A, Yan B, Li R, Boniecki M, Lyons C
Nat Commun. 2025; 16(1):2329.
PMID: 40057496
PMC: 11890592.
DOI: 10.1038/s41467-025-57453-x.
The miR-290 and miR-302 clusters are essential for reprogramming of fibroblasts to induced pluripotent stem cells.
Ye J, Boileau R, Parchem R, Judson-Torres R, Blelloch R
Stem Cells. 2025; 43(2).
PMID: 40037390
PMC: 11879289.
DOI: 10.1093/stmcls/sxae080.
Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cells.
Sahu S, Castro M, Muldoon J, Asija K, Wyman S, Krishnappa N
Nat Protoc. 2025; .
PMID: 40032999
DOI: 10.1038/s41596-025-01154-8.
Engineering of SauriCas9 with enhanced specificity.
Zhang X, Tao C, Li M, Zhang S, Liang P, Huang Y
Mol Ther Nucleic Acids. 2025; 36(1):102455.
PMID: 40027883
PMC: 11869866.
DOI: 10.1016/j.omtn.2025.102455.
Engineered mitochondria in diseases: mechanisms, strategies, and applications.
Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y
Signal Transduct Target Ther. 2025; 10(1):71.
PMID: 40025039
PMC: 11873319.
DOI: 10.1038/s41392-024-02081-y.
Targeting TUBG1 in RB1-negative tumors.
Lindstrom L, Zhou J, Villoutreix B, Malycheva D, Otrocka M, Gustavsson A
FASEB J. 2025; 39(5):e70431.
PMID: 40019206
PMC: 11869804.
DOI: 10.1096/fj.202403180RR.
Hepatic lipid metabolism is altered in Ubiad1 mice of both sexes.
Higa R, Pourteymour S, Kolan P, Dankel S, Ferno J, Mellgren G
Sci Rep. 2025; 15(1):7022.
PMID: 40016272
PMC: 11868635.
DOI: 10.1038/s41598-025-91283-7.
Molecular characterization of the TUBG1 meshwork's influence on Cytoskeletal organization.
Malycheva D, Alvarado-Kristensson M
Heliyon. 2025; 11(2):e41829.
PMID: 40013266
PMC: 11862694.
DOI: 10.1016/j.heliyon.2025.e41829.
Cytosolic CRISPR RNAs for efficient application of RNA-targeting CRISPR-Cas systems.
Cheng E, Lam J, Kwon S
EMBO Rep. 2025; .
PMID: 40011676
DOI: 10.1038/s44319-025-00399-4.
Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson's disease models.
Gao G, Shi Y, Deng H, Krainc D
Nat Commun. 2025; 16(1):1982.
PMID: 40011434
PMC: 11865444.
DOI: 10.1038/s41467-025-57142-9.
Development of cell lines with increased susceptibility to diverse adeno-associated viral vectors to enable potency assays.
Zengel J, Esterman E, Ponnuswami A, Wall N, Carette J
Mol Ther Methods Clin Dev. 2025; 33(1):101416.
PMID: 40008089
PMC: 11851225.
DOI: 10.1016/j.omtm.2025.101416.
Non-Invasive Delivery of CRISPR/Cas9 Ribonucleoproteins (Cas9 RNPs) into Cells via Nanoparticles for Membrane Transport.
Tashima T
Pharmaceutics. 2025; 17(2).
PMID: 40006568
PMC: 11859894.
DOI: 10.3390/pharmaceutics17020201.
Exploring miR-21 Knock-Out Using CRISPR/Cas as a Treatment for Lung Cancer.
Lara P, Aguilar-Gonzalez A, Martin F, Mesas C, Moreno J, Rama A
Genes (Basel). 2025; 16(2).
PMID: 40004462
PMC: 11855122.
DOI: 10.3390/genes16020133.